ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,706.06
0.33%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. CorMedix Inc (CRMD)

  7. CorMedix Inc (CRMD) Noticias

CRMD

CorMedix (CRMD)

CorMedix Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:CRMD
FechaHoraFuenteTítuloSímboloCompañía
28/06/202316:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:CRMDCorMedix Inc
21/06/202307:43Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CRMDCorMedix Inc
19/05/202315:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:CRMDCorMedix Inc
18/05/202317:26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:CRMDCorMedix Inc
17/04/202315:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:CRMDCorMedix Inc
30/03/202307:32Edgar (US Regulatory)Annual Report (10-k)AMEX:CRMDCorMedix Inc
14/02/202309:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:CRMDCorMedix Inc
10/11/202207:17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:CRMDCorMedix Inc
08/07/202216:01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CRMDCorMedix Inc
29/10/202115:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:CRMDCorMedix Inc
12/08/202115:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:CRMDCorMedix Inc
11/02/202116:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:CRMDCorMedix Inc
02/02/202108:16Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:CRMDCorMedix Inc
02/02/202107:31Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:CRMDCorMedix Inc
01/02/202115:01Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...AMEX:CRMDCorMedix Inc
21/01/202107:30GlobeNewswire Inc.CorMedix Inc. to Begin Trading on the Nasdaq Stock ExchangeAMEX:CRMDCorMedix Inc
27/11/202005:04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:CRMDCorMedix Inc
18/11/202007:30GlobeNewswire Inc.CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not NeededAMEX:CRMDCorMedix Inc
05/11/202015:05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business UpdateAMEX:CRMDCorMedix Inc
02/11/202007:30GlobeNewswire Inc.CorMedix Appoints Greg Duncan to its Board of DirectorsAMEX:CRMDCorMedix Inc
08/10/202008:00GlobeNewswire Inc.CorMedix to Participate in BIO Investor Forum DigitalAMEX:CRMDCorMedix Inc
17/09/202007:30GlobeNewswire Inc.CorMedix Appoints Paulo Costa to its Board of DirectorsAMEX:CRMDCorMedix Inc
09/09/202007:30GlobeNewswire Inc.CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceAMEX:CRMDCorMedix Inc
31/08/202006:47GlobeNewswire Inc.CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for DefencathAMEX:CRMDCorMedix Inc
10/08/202015:05GlobeNewswire Inc.CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business UpdateAMEX:CRMDCorMedix Inc
10/08/202007:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:CRMDCorMedix Inc
28/07/202008:21GlobeNewswire Inc.CorMedix Announces Pricing of $20M Public Offering of Common StockAMEX:CRMDCorMedix Inc
27/07/202015:05GlobeNewswire Inc.CorMedix Announces Proposed Public Offering of Common StockAMEX:CRMDCorMedix Inc
08/07/202007:30GlobeNewswire Inc.CorMedix Inc. Reports Submission of Defencath™ New Drug ApplicationAMEX:CRMDCorMedix Inc
11/05/202015:10GlobeNewswire Inc.CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business UpdateAMEX:CRMDCorMedix Inc
 Showing the most relevant articles for your search:AMEX:CRMD

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
FX
EURUSD
Euro vs US Dollar
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
CCOM
SILVER
SILVER
CCOM
US30
US 30
NYSE
NKE
Nike
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
NYSE
AXP
American Express
CCOM
OILBRENT
Brent Oil
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados